Keyphrases
Inducible Nitric Oxide Synthase
100%
Aminoguanidine
100%
Sigma-1 Receptor Agonist
100%
Neuroprotective Drugs
100%
Placebo
50%
Cell Death
33%
Neuroprotection
33%
Histology
16%
Striatum
16%
Possible Mechanisms
16%
Brain Injury
16%
Reperfusion
16%
Transient Middle Cerebral Artery Occlusion (tMCAO)
16%
Neocortex
16%
Ischemic Brain Injury
16%
Inducible Nitric Oxide Synthase Inhibitors
16%
Infarction
16%
2,3,5-triphenyltetrazolium Chloride
16%
Infarct Volume
16%
Mechanisms of Neuroprotection
16%
Pentazocine
16%
Suppressing Cell
16%
Pharmacology, Toxicology and Pharmaceutical Science
Neuroprotective Agent
100%
Receptor Agonist
100%
Inducible Nitric Oxide Synthase
100%
Aminoguanidine
100%
Sigma 1 Opiate Receptor
100%
Placebo
50%
Neuroprotection
50%
Brain Injury
33%
Infarction
33%
Nitric Oxide Synthase Inhibitor
16%
Triphenyltetrazolium
16%
Middle Cerebral Artery Occlusion
16%
Pentazocine
16%
Medicine and Dentistry
Inducible Nitric Oxide Synthase
100%
Neuroprotective Agent
100%
Aminoguanidine
100%
Sigma 1 Opiate Receptor
100%
Placebo
50%
Neuroprotection
50%
Cell Death
33%
Brain Injury
33%
Infarction
33%
Middle Cerebral Artery Occlusion
16%
Nitric Oxide Synthase Inhibitor
16%
Striatum
16%
Triphenyltetrazolium
16%
Pentazocine
16%
Neuroscience
Receptor Agonists
100%
Neuroprotective Agent
100%
Inducible Nitric Oxide Synthase
100%
Sigma 1 Opiate Receptor
100%
Neuroprotection
50%
Placebo
50%
Agonist
33%
Cell Death
33%
Striatum
16%
Middle Cerebral Artery
16%
Pentazocine
16%